Wolman's Disease Terminated Phase 2 / 3 Trials for Sebelipase alfa (DB11563)

Also known as: Wolman Disease / Disease, Wolman / Lipidoses NOS / Cerebrotendinous cholesterosis [van Bogaert-Scherer-Epstein]

IndicationStatusPhase
DBCOND0040271 (Wolman's Disease)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01473875Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102Treatment